At Roundtable, Senator Rosen Announced Her Support For The Bipartisan INSULIN Act To Limit Insulin Costs at $35/Month For Every Nevadan
LAS VEGAS, NV – Last week, U.S. Senator Jacky Rosen (D-NV) hosted a roundtable discussion with Nevada seniors and local health care leaders to discuss the impact of her efforts to lower prescription drug prices and announce her new action to lower costs by supporting the bipartisan INSULIN Act to cap the price of insulin at $35/month for all Nevadans. Thanks to the Rosen-backed Inflation Reduction Act, Nevada seniors are already experiencing lower prices for prescription drugs such as insulin.
Senator Rosen has been a leader in fighting to lower costs for hard-working Nevadans. She recently joined Senate colleagues in filing an amicus brief urging a federal court to uphold the constitutionality of Congress allowing Medicare to negotiate lower drug prices for consumers. Senator Rosen also helped pass the Inflation Reduction Act to help lower costs and put dollars back in the pockets of hard-working Nevadans, which included provisions to lower health care premiums, and lower prescription drug costs by allowing Medicare to negotiate the price of prescription drugs for seniors. Last Congress, Senator Rosen introduced the bipartisan Advancing Affordable Medicines for Families Act to examine the impact that nonprofit generic drug companies would have on lowering drug costs, addressing drug shortages, and accelerating the development of new drugs, which was passed into law.
By Casey Harrison
- Las Vegas resident David Berman’s daily routine has been consistent for nearly his entire life: It revolves around taking his daily doses of insulin.
- Prior to each meal and before going to bed each night, the retired attorney takes a dose of insulin to treat his Type 1 diabetes. In between, the transplant from the Boston area who has called Southern Nevada home for the past 23 years charts his blood glucose levels to ensure he’s properly handling the ailment.
- Berman saw immediate relief come earlier this year after a section of the Inflation Reduction Act went into effect, allowing Medicare to negotiate the price of several popular prescription medications and capping the price of a month’s supply of insulin at $35.
- “I was an immediate beneficiary of the drop in insulin rates,” Berman said at a roundtable discussion about prescription drug affordability at Roseman University in Henderson. “We were paying the $70 a month (per dose) and starting at the beginning of the year, $35 a month. That adds up.”
- The roundtable was led by Sen. Jacky Rosen, D-Nev., who was joined by Meena Seshamani, director of the Center for Medicare, whose administration operates the public health insurer.
- Rosen said Tuesday she signed on as a cosponsor last week to the Insulin Act of 2023, which would eliminate deductibles and other “cost-sharing requirements” related to insulin and cap its price at $35 for a 30-day supply for private-sector health insurance beneficiaries. She joins a bipartisan group of senators — five Republicans and five Democrats — cosponsoring the act.
- “It’s the most important thing to everyone, for their own health and the health of people they love, to be able to afford them,” Rosen said. “And not having to make that choice between your rent or your food or rationing your medication or not taking it at all.”
Reporter: “There’s already been a huge change for seniors on insulin. The Medicare price was capped at $35 per month earlier this year as part of the Inflation Reduction Act. Now, Senator Jacky Rosen wants to expand who and what is covered.”
Senator Rosen: “Over a quarter million people in Nevada that we know of are insulin-dependent diabetics, some of them paying $400 or $500 a month.”
Reporter: “Senator Rosen now sponsoring legislation to reduce the cost of the life-saving drug for all.”
Senator Rosen: “The Insulin Act, which is going to bring that $35 insulin to everyone in the country.”
Reporter: “Our Nevada Senator, Jacky Rosen, is hosting a discussion about lowering prescription drug costs here in Las Vegas […] She is expected to talk with Nevada seniors and health care leaders about actions to lower those prescription drug costs, and she’s also expected to announce new action she’s taking to help bring down the cost of medications.”
Univision Las Vegas: Rosen anuncia esfuerzos para reducir los costos de medicamentos
Reportera: “Esta mañana la senadora por Nevada Jacky Rosen tuvo la oportunidad de conversar con beneficiarios del Medicare en torno a la Ley de reducción de la Inflación. La misma que contó con el apoyo de Rosen, logró que el precio de la insulina se fijará en $35 para quienes usan Medicare. Además, explicó que impulsan otro proyecto para que cualquier persona, sin importar su seguro o cobertura, pueda compartir, o comprar, mejor dicho, esta medicina a esos mismos $35.”
Telemundo Las Vegas: Rosen encabeza discusión sobre precios de medicamentos
Reportera: “La senadora estatal Jacky Rosen hoy presentó el acto de reducción y sus esfuerzos para mejorar los costos de los medicamentos para los nevadenses de la tercera edad. A la reunión, de hecho, asistieron médicos y pacientes que enfrentaban retos para comprar medicamentos y discutieron las formas para mejorar el acceso a estos fármacos.”